| Q39782919 | Activation of PERK kinase in neural cells by proteasome inhibitor treatment |
| Q37062266 | Antioxidants Enhance Mammalian Proteasome Expression through the Keap1-Nrf2 Signaling Pathway |
| Q31135318 | Catalytic site-specific inhibition of the 20S proteasome by 4-hydroxynonenal |
| Q37217435 | Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. |
| Q33810650 | Circulating proteasome activity following mild head injury in children |
| Q41107536 | Copper(II) ions affect the gating dynamics of the 20S proteasome: a molecular and in cell study |
| Q48371719 | Effects of mode of delivery on maternal-neonatal plasma antioxidant status and on protein S100B serum concentrations |
| Q53821856 | Effects of mulberry leaves on production performance and the potential modulation of antioxidative status in laying hens. |
| Q38928502 | Functional interaction between cyclooxygenase-2 and p53 in response to an endogenous electrophile. |
| Q42911232 | Identification of p10 as a neurotoxic product generated from the proteolytic cleavage of the neuronal Cdk5 activator |
| Q35959137 | Idiopathic Recurrent Calcium Urolithiasis (IRCU): pathophysiology evaluated in light of oxidative metabolism, without and with variation of several biomarkers in fasting urine and plasma--a comparison of stone-free and -bearing male patients, emphas |
| Q48308588 | Intrastriatal hypoxanthine reduces Na(+),K (+)-ATPase activity and induces oxidative stress in the rats. |
| Q45004411 | Lactacystin-induced apoptosis of cultured mouse cortical neurons is associated with accumulation of PTEN in the detergent-resistant membrane fraction. |
| Q36841249 | Methionine sulfoxide reductase A protects dopaminergic cells from Parkinson's disease-related insults |
| Q36710261 | Oxidative and nitrative protein modifications in Parkinson's disease |
| Q48586917 | Proteasome inhibition by MG-132 induces apoptotic cell death and mitochondrial dysfunction in cultured rat brain oligodendrocytes but not in astrocytes |
| Q44539005 | Proteasome inhibition by chronic oxidative stress in human trabecular meshwork cells |
| Q33871372 | Proteasome inhibition modulates kinase activation in neural cells: relevance to ubiquitination, ribosomes, and survival |
| Q46723184 | Protective effect of carnosine during nitrosative stress in astroglial cell cultures |
| Q48305092 | Redox Pioneer: Professor Barry Halliwell |
| Q34400646 | Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment |
| Q37802176 | The Nrf2 system as a potential target for the development of indirect antioxidants. |
| Q46328313 | The effect of the mode of delivery on the maternal-neonatal carnitine blood levels and antioxidant status |
| Q35859776 | The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. |
| Q46069618 | The small heat shock protein HSP25 protects astrocytes against stress induced by proteasomal inhibition |
| Q33892755 | The ubiquitin-proteasome system as a drug target in cerebrovascular disease: therapeutic potential of proteasome inhibitors |
| Q60044067 | UVB-mediated down-regulation of proteasome in cultured human primary pterygium fibroblasts |
| Q48100947 | Up‐regulation of endoplasmic reticulum stress‐related genes during the early phase of treatment of cultured cortical neurons by the proteasomal inhibitor lactacystin |